The RHN has partnered with Sanome

The Royal Hospital for Neuro-disability (RHN) has partnered with Sanome to pilot an AI-based infection-detection tool called MEMORI. Launched at RHN in December 2025, the system will initially be used across four wards to support clinicians assisting patients with complex neurological conditions, who are particularly vulnerable to infections. Embedded within the PatientSource electronic health record system, MEMORI uses explainable AI to analyse real-time patient data, helping teams identify infection risks earlier and more confidently.

Sanome is also working with East Kent Hospitals NHS Foundation Trust, with bedside deployments planned soon and additional NHS rollouts in 2026. These collaborations aim to develop a scalable model for using real-time NHS data that could benefit many patients across multiple hospitals.

Benedikt von Thüngen, founder and chief executive of Sanome, said:

“Partnering with leading healthcare organisations like the Royal Hospital for Neuro-disability marks an important step towards bringing earlier, data-driven infection detection into everyday care. By working closely with clinicians, we’ve co-created a platform that not only flags patients at risk, but fits seamlessly into existing workflows — helping teams intervene sooner.”

In August 2025, the MEMORI platform obtained approval from the Medicines and Healthcare products Regulatory Agency (MHRA) and received EU Class IIb CE certification, paving the way for its deployment across the UK and Europe.

This collaboration demonstrates RHN’s ongoing dedication to utilising innovation and technology to improve patient safety, support clinical teams, and enhance outcomes for individuals with complex neuro-disabilities.